14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ISCV vs IMCG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, iShares Morningstar Small-Cap Value ETF (ISCV) is the stronger overall head-to-head candidate over iShares Morningstar Mid-Cap Growth ETF (IMCG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ISCV carries a Unified Composite Score of 42.8/100 (HOLD) at $78.15 (N/M Forward P/E, N/A operating margin), whereas IMCG carries 43.9/100 (HOLD) at $91.30 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While IMCG currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. ISCV 42.8/100 HOLD), ISCV captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: ISCV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.7); meanwhile IMCG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ISCV vs IMCG. Trailing 12-month operating profitability (ISCV N/A vs IMCG N/A) and valuation multiples (ISCV N/M vs IMCG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ISCV vs IMCG Key Questions & Quantitative Answers
As of Nov 16, 2026, iShares Morningstar Small-Cap Value ETF (ISCV) is the stronger overall head-to-head candidate over iShares Morningstar Mid-Cap Growth ETF (IMCG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ISCV carries a Unified Composite Score of 42.8/100 (HOLD) at $78.15 (N/M Forward P/E, N/A operating margin), whereas IMCG carries 43.9/100 (HOLD) at $91.30 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IMCG currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. ISCV 42.8/100 HOLD), ISCV captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: ISCV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.7); meanwhile IMCG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ISCV and IMCG split Growth & Scale metrics: ISCV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IMCG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ISCV generates N/A in USD-normalized revenue versus N/A for IMCG. In operating R&D and SG&A reinvestment, ISCV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IMCG.
ISCV and IMCG trade at balanced relative valuation multiples. ISCV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IMCG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ISCV (N/A ROE) versus IMCG (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ISCV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.65β · 20% Vol realized risk). By comparison, IMCG carries 15.6% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.20β · 27% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.